• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性胶质瘤患者连续生活质量评估的收集与解读中的实际问题。

Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma.

作者信息

Walker M, Brown J, Brown K, Gregor A, Whittle I R, Grant R

机构信息

Edinburgh Centre for Neuro-Oncology, Western General Hospital, Edinburgh, Scotland, UK.

出版信息

J Neurooncol. 2003 Jun;63(2):179-86. doi: 10.1023/a:1023900802254.

DOI:10.1023/a:1023900802254
PMID:12825822
Abstract

OBJECTIVES

To assess the problems involved with the collection and interpretation of serial collected health related quality of life assessments in patients with malignant glioma.

PATIENTS AND METHODS

One-hundred and fifty nine patients with malignant glioma from three Scottish neurosurgical centres in whom assessments of performance status, neurological impairment, mood, and quality of life had been recorded over a 6-month period were prospectively identified. The amount of missing data and the reasons for missing data were assessed. Characteristics of patients that were fully compliant with serial assessments were then compared with those that were not.

RESULTS

Compliance with serial assessments (both patient and observer reported) was poor, dropping to less than 50% at 6 months. Observer reported measures showed a similar pattern of decline as patient reported measures. The largest single cause of missing data (approximately 70%) was due to administrative failure. Compliant patients were found to have a significantly greater probability of survival compared to non-compliant patients and were also found to be younger and fitter relative to the rest of the study population.

CONCLUSIONS

Studies utilising quality of life outcomes should give early consideration to minimising avoidable sources of missing data and recording the reasons for non-compliance. Quality of life studies basing conclusions on a complete case analysis should be wary of possible bias.

摘要

目的

评估恶性胶质瘤患者连续收集的健康相关生活质量评估的收集和解读中所涉及的问题。

患者与方法

前瞻性地确定了来自苏格兰三个神经外科中心的159例恶性胶质瘤患者,这些患者在6个月期间记录了其功能状态、神经功能损害、情绪和生活质量评估情况。评估了缺失数据的数量和缺失数据的原因。然后将完全依从连续评估的患者特征与未依从的患者特征进行比较。

结果

连续评估的依从性(患者和观察者报告)较差,6个月时降至50%以下。观察者报告的测量结果与患者报告的测量结果显示出相似的下降模式。缺失数据的最大单一原因(约70%)是管理失误。发现依从的患者与不依从的患者相比有显著更高的生存概率,并且相对于研究人群的其他部分,他们也更年轻、身体状况更好。

结论

利用生活质量结果的研究应尽早考虑尽量减少可避免的缺失数据来源并记录不依从的原因。基于完整病例分析得出结论的生活质量研究应警惕可能的偏倚。

相似文献

1
Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma.恶性胶质瘤患者连续生活质量评估的收集与解读中的实际问题。
J Neurooncol. 2003 Jun;63(2):179-86. doi: 10.1023/a:1023900802254.
2
Causes and Consequences of Missing Health-Related Quality of Life Assessments in Patients Who Undergo Mechanical Circulatory Support Implantation: Insights From INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).接受机械循环支持植入的患者中与健康相关的生活质量评估缺失的原因及后果:来自INTERMACS(机械辅助循环支持跨机构注册中心)的见解
Circ Cardiovasc Qual Outcomes. 2017 Dec;10(12):e003268. doi: 10.1161/CIRCOUTCOMES.116.003268.
3
Health-related quality of life in high-grade glioma patients.高级别胶质瘤患者的健康相关生活质量
Chin J Cancer. 2014 Jan;33(1):40-5. doi: 10.5732/cjc.013.10214.
4
Perioperative and Postoperative Quality of Life in Patients with Glioma-A Longitudinal Cohort Study.胶质瘤患者围手术期和术后生活质量——一项纵向队列研究
World Neurosurg. 2018 Sep;117:e465-e474. doi: 10.1016/j.wneu.2018.06.052. Epub 2018 Jun 18.
5
Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.恶性胶质瘤的质量调整生存分析。接受每日两次放疗(RT)和卡莫司汀治疗的患者:放射治疗肿瘤学组(RTOG)83-02的报告。
Int J Radiat Oncol Biol Phys. 1995 Feb 1;31(3):453-9. doi: 10.1016/0360-3016(95)93160-9.
6
Depression in patients with high-grade glioma: results of the Glioma Outcomes Project.高级别胶质瘤患者的抑郁:胶质瘤结局项目的结果
Neurosurgery. 2004 Feb;54(2):358-66; discussion 366-7. doi: 10.1227/01.neu.0000103450.94724.a2.
7
Facets and determinants of quality of life in patients with recurrent high grade glioma.复发性高级别胶质瘤患者生活质量的方面及决定因素
J Neurol Neurosurg Psychiatry. 2005 Apr;76(4):562-8. doi: 10.1136/jnnp.2004.036186.
8
Reporting of patient-reported health-related quality of life in adults with diffuse low-grade glioma: a systematic review.弥漫性低级别胶质瘤成年患者自我报告的健康相关生活质量报告:一项系统综述
Neuro Oncol. 2016 Nov;18(11):1475-1486. doi: 10.1093/neuonc/now107. Epub 2016 May 18.
9
Malignant cerebral glioma--II: Perspectives of patients and relatives on the value of radiotherapy.恶性脑胶质瘤——II:患者及亲属对放疗价值的看法
BMJ. 1996 Dec 14;313(7071):1512-6. doi: 10.1136/bmj.313.7071.1512.
10
Cognitive functioning in long-term survivors of high-grade glioma.高级别胶质瘤长期幸存者的认知功能
J Neurosurg. 1994 Feb;80(2):247-53. doi: 10.3171/jns.1994.80.2.0247.

引用本文的文献

1
The problem of missing data for learning health systems focused on first-episode psychosis.针对首发精神病的学习型健康系统中的数据缺失问题。
Schizophr Res. 2025 May;279:79-86. doi: 10.1016/j.schres.2025.03.021. Epub 2025 Apr 2.
2
Health-related quality of life analysis from ENTER, a randomized, controlled phase III trial of whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases.来自ENTER的健康相关生活质量分析,这是一项关于非小细胞肺癌脑转移患者全脑放疗联合或不联合厄洛替尼的随机对照III期试验。
Transl Lung Cancer Res. 2024 Dec 31;13(12):3289-3302. doi: 10.21037/tlcr-24-481. Epub 2024 Dec 27.
3

本文引用的文献

1
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.一项针对多形性胶质母细胞瘤首次复发患者的替莫唑胺与丙卡巴肼对比的II期研究。
Br J Cancer. 2000 Sep;83(5):588-93. doi: 10.1054/bjoc.2000.1316.
2
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.替莫唑胺用于间变性星形细胞瘤或间变性少突星形细胞瘤首次复发患者的多中心II期试验。替莫唑胺脑肿瘤研究组。
J Clin Oncol. 1999 Sep;17(9):2762-71. doi: 10.1200/JCO.1999.17.9.2762.
3
Significant change in tests of neurological impairment in patients with brain tumours.
Association between patient-reported cognitive function and location of glioblastoma.
患者报告的认知功能与胶质母细胞瘤位置之间的关联。
Neurosurg Rev. 2023 Oct 25;46(1):282. doi: 10.1007/s10143-023-02177-z.
4
Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers.抗寄生虫药甲苯咪唑作为治疗脑癌的再利用药物的新观点。
Int J Mol Sci. 2023 Jan 10;24(2):1334. doi: 10.3390/ijms24021334.
5
Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic.放射肿瘤诊所中脑转移瘤患者的生活质量与认知功能评估及干预
Cancers (Basel). 2022 Sep 1;14(17):4301. doi: 10.3390/cancers14174301.
6
A Prospective Study on Health-Related Quality of Life and Patient-Reported Outcomes in Adult Brain Tumor Patients Treated with Pencil Beam Scanning Proton Therapy.一项关于接受笔形束扫描质子治疗的成人大脑肿瘤患者健康相关生活质量和患者报告结局的前瞻性研究。
Cancers (Basel). 2021 Sep 29;13(19):4892. doi: 10.3390/cancers13194892.
7
Impact of neurosurgical enhanced recovery after surgery (ERAS) program on health-related quality of life in glioma patients: a secondary analysis of a randomized controlled trial.神经外科加速康复外科(ERAS)方案对脑胶质瘤患者健康相关生活质量的影响:一项随机对照试验的二次分析。
J Neurooncol. 2020 Jul;148(3):555-567. doi: 10.1007/s11060-020-03548-y. Epub 2020 Jun 6.
8
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study.神经认知功能和成年髓母细胞瘤患者的健康相关生活质量:NOA-07 研究的长期结果。
J Neurooncol. 2020 May;148(1):117-130. doi: 10.1007/s11060-020-03502-y. Epub 2020 May 4.
9
Proton therapy re-irradiation preserves health-related quality of life in large recurrent glioblastoma.质子治疗挽救大复发胶质母细胞瘤患者的健康相关生活质量。
J Cancer Res Clin Oncol. 2020 Jun;146(6):1615-1622. doi: 10.1007/s00432-020-03187-w. Epub 2020 Mar 21.
10
Perioperative fatigue in patients with diffuse glioma.弥漫性胶质瘤患者的围手术期疲劳。
J Neurooncol. 2020 Mar;147(1):97-107. doi: 10.1007/s11060-020-03403-0. Epub 2020 Jan 23.
J Neurooncol. 1998 Aug;39(1):81-90. doi: 10.1023/a:1005950003774.
4
Identifying the types of missingness in quality of life data from clinical trials.识别来自临床试验的生活质量数据中的缺失类型。
Stat Med. 1998;17(5-7):739-56. doi: 10.1002/(sici)1097-0258(19980315/15)17:5/7<739::aid-sim818>3.0.co;2-m.
5
Suggestions for the presentation of quality of life data from clinical trials.
Stat Med. 1998;17(5-7):711-24. doi: 10.1002/(sici)1097-0258(19980315/15)17:5/7<711::aid-sim816>3.0.co;2-h.
6
Statistical analysis of quality of life with missing data in cancer clinical trials.癌症临床试验中存在缺失数据时的生活质量统计分析。
Stat Med. 1998;17(5-7):653-66. doi: 10.1002/(sici)1097-0258(19980315/15)17:5/7<653::aid-sim812>3.0.co;2-m.
7
Ensuring the quality of quality of life data: the Southwest Oncology Group experience.确保生活质量数据的质量:西南肿瘤协作组的经验
Stat Med. 1998;17(5-7):641-51. doi: 10.1002/(sici)1097-0258(19980315/15)17:5/7<641::aid-sim811>3.0.co;2-w.
8
Practical issues in quality of life assessment in multicentre trials conducted by the Swiss Group for Clinical Cancer Research.瑞士临床癌症研究组织开展的多中心试验中生活质量评估的实际问题。
Stat Med. 1998;17(5-7):633-9. doi: 10.1002/(sici)1097-0258(19980315/15)17:5/7<633::aid-sim810>3.0.co;2-u.
9
Quality of life as an endpoint in EORTC clinical trials. European Organization for Research and Treatment for Cancer.生活质量作为欧洲癌症研究与治疗组织(EORTC)临床试验的终点指标。欧洲癌症研究与治疗组织
Stat Med. 1998;17(5-7):561-9. doi: 10.1002/(sici)1097-0258(19980315/15)17:5/7<561::aid-sim803>3.0.co;2-s.
10
Missing quality of life data in cancer clinical trials: serious problems and challenges.癌症临床试验中生活质量数据缺失:严重问题与挑战
Stat Med. 1998;17(5-7):517-32. doi: 10.1002/(sici)1097-0258(19980315/15)17:5/7<517::aid-sim799>3.0.co;2-s.